SHORTAGES OF DRUGS WITH APPROVED ORPHAN INDICATIONS IN THE UNITED STATES

被引：0
|
作者：
Felemban, D. [1 ]
Ghazawi, K. [1 ]
Alsheikh, M. [1 ]
Seoane-Vazquez, E. [2 ]
Rodriguez-Monguio, R. [3 ]
Fox, E. R. [4 ]
Szeinbach, S. L. [5 ]
机构：
[1] Massachusetts Coll Pharm & Hlth Sci, Boston, MA USA
[2] Massachusetts Coll Pharm & Hlth Sci, Int Ctr Pharmaceut Econ & Policy, Boston, MA USA
[3] Univ Massachusetts, Amherst, MA 01003 USA
[4] Univ Utah Hosp & Clin, Salt Lake City, UT USA
[5] Ohio State Univ, Columbus, OH 43210 USA
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.145
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP81
引用
收藏
页码：A23 / A23
页数：1
相关论文
共 50 条
  • [1] Orphan drugs: The United States experience
    Haffner, ME
    [J]. DRUG INFORMATION JOURNAL, 1999, 33 (02): : 565 - 568
  • [2] Orphan Drugs: The United States Experience
    Marlene E. Haffner
    [J]. Drug information journal : DIJ / Drug Information Association, 1999, 33 (2): : 565 - 568
  • [3] Spending For Orphan Indications Among Top-Selling Orphan Drugs Approved To Treat Common Diseases
    Chua, Kao-Ping
    Kimmel, Lauren E.
    Conti, Rena M.
    [J]. HEALTH AFFAIRS, 2021, 40 (03) : 453 - 460
  • [4] ORPHAN DRUGS' MARKET ACCESS IN THE UNITED STATES
    Doyle, J. J.
    Sepulveda, B.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A8 - A8
  • [5] Adjuncts for ovarian stimulation: when do we adopt "orphan indications" for approved drugs?
    Meldrum, David R.
    Chang, R. Jeffrey
    de Ziegler, Dominique
    Schoolcrcft, William B.
    Scott, Richard T., Jr.
    Pellicer, Antonio
    [J]. FERTILITY AND STERILITY, 2009, 92 (01) : 13 - 18
  • [6] Disentangling the Cost of Orphan Drugs Marketed in the United States
    Althobaiti, Hana
    Seoane-Vazquez, Enrique
    Brown, Lawrence M.
    Fleming, Marc L.
    Rodriguez-Monguio, Rosa
    [J]. HEALTHCARE, 2023, 11 (04)
  • [7] Orphan diseases and treatments including orphan drugs and some orphan indications
    Garattini, S
    [J]. EUROPEAN MEDICINES RESEARCH: PERSPECTIVES IN CLINICAL TRIALS, 1996, : 117 - 124
  • [8] International comparison of availability for orphan drugs: focused on approved orphan drugs in South Korea
    Shin, Eun Young
    Hong, Young Jun
    Lim, Kyung Min
    Kim, Tae Hyang
    Lee, Jong Hyuk
    [J]. JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
  • [9] TRENDS OF ORPHAN DRUGS APROVALS OVER TIME IN THE UNITED STATES
    Thokagevistk, K.
    Dorey, J.
    Tavella, F.
    Remuzat, C.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A234 - A234
  • [10] Orphan drugs: The current situation in the United States, Europe, and Asia
    Meyers A.S.
    [J]. Drug information journal : DIJ / Drug Information Association, 1997, 31 (1): : 101 - 104
12345